A Chinese criminal organization implicated in fentanyl trafficking has allegedly leveraged a base in Japan to conduct large-scale cryptocurrency fraud, including the distribution of a scam token that defrauded victims globally of over $1 million. The organization, linked to the Chinese chemical company Hubei Amavel Biotech, reportedly used its Japanese operations, including a corporation named FIRSKY in Nagoya, as a hub for logistics and financial management.
Nikkei's investigation, analyzing court evidence and blockchain transactions, revealed that Amavel frequently exchanged funds with a Chinese fraud organization. This led to suspicions that Amavel was involved in distributing a fraudulent token named 'zksync.jp,' which mimicked a legitimate service and exploited the credibility of the '.jp' domain. Victims who interacted with the token reportedly lost significant sums, with estimates in Japan alone reaching hundreds of millions of yen.
The U.S. Drug Enforcement Administration has acknowledged that Japan is being used as a transit point for illegal fentanyl exports, raising concerns that it may also be exploited as a financial conduit for concealing criminal proceeds. This case highlights the increasing diversification of transnational crime networks into cryptocurrency fraud alongside traditional illicit activities like drug trafficking.